Molecular imaging in drug discovery and development

By Markus Rudin, Ralph Weissleder. Nature reviews. Drug discovery, 2003

816 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Deformable Medical Image Registration: A Survey (2013, background): “The exact same concept is applicable when developing and evaluating new drugs where imaging studies need to be normalized and mapped to the same space towards interpretation [17].”
Molecular imaging in drug development (2008, background): “PET in particular allows assessment of parameters such as drug absorption, biodistribution, metabolism, delivery and dose issues in preclinical studies and can help in planning later phase”
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine (2012, neutral): “Above the Néel temperature, the substance becomes paramagnetic (Figure 2) [61,62].”
Clinical biomarkers in drug discovery and development (2003, neutral): “Microimaging There are many developments in the field of imaging that could be incorporated into drug discovery and development programme”